Enhanced Aβ1–40 Production in Endothelial Cells Stimulated with Fibrillar Aβ1–42
Open Access
- 7 March 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (3) , e58194
Abstract
Amyloid accumulation in the brain of Alzheimer’s patients results from altered processing of the 39- to 43-amino acid amyloid β protein (Aβ). The mechanisms for the elevated amyloid (Aβ1–42) are considered to be over-expression of the amyloid precursor protein (APP), enhanced cleavage of APP to Aβ, and decreased clearance of Aβ from the central nervous system (CNS). We report herein studies of Aβ stimulated effects on endothelial cells. We observe an interesting and as yet unprecedented feedback effect involving Aβ1–42 fibril-induced synthesis of APP by Western blot analysis in the endothelial cell line Hep-1. We further observe an increase in the expression of Aβ1–40 by flow cytometry and fluorescence microscopy. This phenomenon is reproducible for cultures grown both in the presence and absence of serum. In the former case, flow cytometry reveals that Aβ1–40 accumulation is less pronounced than under serum-free conditions. Immunofluorescence staining further corroborates these observations. Cellular responses to fibrillar Aβ1–42 treatment involving eNOS upregulation and increased autophagy are also reported.Keywords
This publication has 56 references indexed in Scilit:
- Proteolytic Degradation of Amyloid -ProteinCold Spring Harbor Perspectives in Medicine, 2012
- Proteolytic processing of Alzheimer’s β‐amyloid precursor proteinJournal of Neurochemistry, 2011
- APP physiological and pathophysiological functions: insights from animal modelsCell Research, 2011
- NADPH-oxidase activation and cognition in Alzheimer disease progressionFree Radical Biology and Medicine, 2011
- The vascular contribution to Alzheimer's diseaseClinical Science, 2010
- Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s diseaseActa Neuropathologica, 2009
- Degradation of fibrillar forms of Alzheimer's amyloid β-peptide by macrophagesNeurobiology of Aging, 2008
- A Century of Alzheimer's DiseaseScience, 2006
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996